The United States. F D A on 17-SEP-2010 has made an announcement that they are reviewing preliminary safety information about Drug Actos (pioglitazone) a anti diabetes drug .
FDA is reviewing safety as it is reported that the drug may be associated with risk of bladder cancer, after receiving preliminary results from a long-term observational study designed to evaluate the use of this drug.
FDA states in their press release that the preliminary results are based up on ongoing, 10-year observational study by the pharmaceutical manufacturer, Takeda Pharmaceuticals, an North America Inc., San Diego. and the data collected is five-year data .
Early results did not showed any association of Drug Actos (pioglitazone) exposure and and risk of bladder cancer. How ever it is being evaluated by FDA for possibilities association with risk of bladder cancer in patients with the longest exposure to Actos and in those with the highest cumulative dose of the drug .
FDA stated in their press release that they have not yet concluded that Actos increases the risk of bladder cancer.
Information about Actos (pioglitazone)
Pioglitazone stimulates the nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR-γ) , PPAR-α , there by enhancing the trascription of insuline sensitive genes responsible for glucose and lipid metabolism taking place in adipose and musclular tissue and in liver , as a result pioglitazone reduces the resistance of insulin in periferal tissue and liver. Drug Avandia (rosiglitazone) is the other only one drug that also belongs to class of drug peroxisome proliferator-activated receptor (PPAR) agonists.
FDA stated in press release that they don’t have any clinical information associating other drug Avandia with bladder cancer in patients receiving that drug.
As US FDA has not concluded the result of review of the association between use of Actos (pioglitazone) and increased risk of bladder cancer. FDA has asked patients to talk to their health care professional, and they should not stop taking the drug unless asked to do so by their health care professional.
=====================================================================================================
Do you know now this website has become a most popular and most referred website in pharmaceutical industry and pharmaceutical companies and pharmaceutical manufacturers from all over the world ,for almost all topics related to Pharmaceutical Manufacturing , Pharmaceutical Regulatory Affairs and Good Manufacturing Practice for Pharmaceutical Manufacturing (c GMP guidelines ) and latest news and new drugs developments.
=====================================================================================================
You may also like following articles
Whar is Referance Listed Drug ? ( RLD )
What is Pharmaceutical Equivalents
What is Pharmaceutical Alternatives
What is Therapeutic Equivalents
Do Physical properties contribute to drug activity.
What is drug receptor , How a drug resistance occurs
Drug interaction, and its examples
What is first pass metabolism of a drug
What is What is 510(k) Clearances ?
Premarket Notification for medical devices – PMN or 510(k)
Antibiotic Definition and classification
Antibiotic resitance and Antibiotic resistance mechanism
Vitamin D Details on FDA cautions on accurate dosage of Vitamin D
What is an antibody? what is monoclonal and polyclonal antibodies?
Terminologies In vaccine Production
Multi stage testing of Virus vaccine production
Testing of vaccines at different stages of production
TESTING FOR ADVENTITIOUS AGENTS CELL PROPERTIES IN VIRAL VACCINE PRODUCTION
Enzyme linked immunosorbent assay ELISA
http://whoguideline.blogspot.com/2010/04/terminalogy-and-their-explanations.html
Pharmaceutical Aseptic Manufacturing Process Terms , Terminology and Definitions.
http://whoguideline.blogspot.com/2010/02/pharmaceutical-aseptic-manufacturing.html
Here are some articles which will be useful for you in further understanding of aspects of sterile dosage form manufacturing and regulatory affairs and good manufacturing practice in
Types of validations in pharmaceutical manufacturing
Requirements of documents for validation of sterilisation process
How to investigate OOS out of specification results
Determination of Phenol coefficient of a disinfectant
Time limitations in sterile pharmaceuticals processing
Aspects of validation of manufacturing process in sterile pharmaceuticals
Controlling Pyrogens in injectable dosage forms
Media fill run process simulation aspects Validation of Aseptic Process and Sterilisation
New Drug Application (NDA) how to make a New Drug Application (NDA) to US FDA
How to make Investigational New Drug (IND) Application to US FDA
Drug applications submission to us fda Over the counter Drugs OTC drugs
BIOAVAILABILITY AND BIOEQUIVALENCE REQUIREMENTS
Electronic record in pharmaceutical manufacturing industry
Good manufacturing practice in pharmaceutical industry
Pharmaceutical industry pharmaceutical companies and FDA latest updates
Here is an interesting article on world wide pharmaceutical industry and making a carrier in one of pharmaceutical companies article on Pharmaceutical Industry pharmaceutical industry
Find a Job in Pharmaceutical Company
To Find Pharmaceutical jobs and make a Pharmaceutical careers see here pharmaceutical companies
Here are some interesting articles on Quality assurance systems for pharmaceutical company
1.Quality assurance in pharma industry
2.Quality by designe concept for pharmaceutical industry
3.Quality by designe concept in pharmaceutical industryan explanation
Guidelines on Pharmaceutical Manufacturing Pharma Quality Assurance Quality Management System 
Leave a Reply